radiolabeled Tx3.833

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameradiolabeled Tx3.833
Drug Alias NameTX3.833-ricinunconjugated TX3.833immunotoxin (Beth Israel)125I-Tx3.833
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A